Skip to main content

JPMORGAN CHASE & CO

Position in NBIX — Neurocrine Biosciences Inc

CIK 19617 NEW YORK, NY

Position in NBIX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$716,937,900
-$20,628,582 QoQ
Shares Held
5,442,067
+4.6% QoQ
Ownership
5.41%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 90.41564537886065.ToString("F0")% Shared 0.36186618062585413.ToString("F0")% None 9.222488440513503.ToString("F0")%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

JPMORGAN CHASE & CO holds $2,053,486,049 across 61 Drug Manufacturers - Specialty & Generic names. NBIX ranks #1 (34.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NBIX
Neurocrine Biosciences Inc
This page
5,442,067 $716,937,900

All Filings in NBIX

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $716,937,900 5,442,067
2025-12-31 $737,566,482 5,200,356
2025-09-30 $664,018,732 4,730,152
2025-06-30 $535,658,975 4,261,747
2025-03-31 $295,412,373 2,670,998
2024-12-31 $187,166,886 1,371,186
2024-09-30 $172,591,603 1,497,931
2024-06-30 $325,277,721 2,362,735
2024-03-31 $316,541,286 2,295,108
2023-12-31 $228,675,139 1,735,543
2023-09-30 $203,764,161 1,811,237
2023-06-30 $185,004,712 1,961,874
2023-03-31 $218,231,222 2,156,009
2022-12-31 $259,192,201 2,170,062
2022-09-30 $251,849,076 2,371,237
2022-06-30 $292,221,638 2,997,760
2022-03-31 $281,747,714 3,005,309
2021-12-31 $253,900,197 2,981,099
2021-09-30 $257,949,749 2,689,498
2021-06-30 $140,838,970 1,447,174
2021-03-31 $149,357,617 1,535,811
2020-12-31 $91,370,256 953,263
2020-09-30 $73,608,362 765,478
2020-06-30 $88,054,354 721,757
2020-03-31 $39,978,394 461,911